A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium

20240 citationsJournal Articlegold Open Access

Authors

Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Good health and well-being

Published in: Ophthalmology Science

Volume 4, Issue 4, pp. 100502-100502

Field-Weighted Citation Impact: 0.00